Fighting Drug Resistance in Bacteria

  • Author: Adrian Neal
  • Published: 07 March 2016
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
  • Source / Publisher: MedChemComm/Royal Society of Chemistry (RSC)
  • Associated Societies: Royal Society of Chemistry (RSC), UK
thumbnail image: Fighting Drug Resistance in Bacteria

Methicillin-resistant Staphylococcus aureus (MRSA) infections are notoriously difficult to treat. This so-called "superbug" is increasingly resistant even to vancomycin, often a drug of last resort, and therefore new classes of antibiotic drugs are urgently required.


Gui-Xin Cai, Cheng-He Zhou, and colleagues, Southwest University, Chongqing, China, have synthesized a series of imidazole naphthalimides and tested them against a panel of bacteria and fungi. Azole-containing drugs are known for their antimicrobial properties – the imidazole-based metronidazole is a well-known example from the clinic. Naphthalimides are important pharmacophores that interfere with protein–DNA interactions, which combats cancer cells and bacteria.


The lead compound in the series, a nitrobenzyl derivative (pictured), inhibits the growth of MRSA and other strains with improved activity over the clinically used chloromycin and norfloxacin. The fast rate of action suggests that permeabilization of the bacterial cell membrane is involved. Preliminary experiments also show that the compound can avoid the bacteria's efforts to develop drug resistance, which might prove to be an advantageous property for new antibiotics.


 

Article Views: 1797

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH